LUMINANCE: A Phase IIIb Study of Durvalumab plus Platinum-Etoposide for First-Line Treatment of Extensive-Stage SCLC (ES-SCLC)

Reinmuth N., DeMarinis F., Leighl N., Sadow S., Davey K., ÖZGÜROĞLU M.

JOURNAL OF THORACIC ONCOLOGY, vol.17, no.9, 2022 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 17 Issue: 9
• Publication Date: 2022
• Journal Name: JOURNAL OF THORACIC ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
• Keywords: Extensive-stage SCLC, Durvalumab, LUMINANCE
• Istanbul University Affiliated: No